We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
We’re taking innovative action to reduce the impact of crime on society.
Managing radioactive waste with geological disposal
This guidance outlines how to create and implement a cloud strategy, and when to consider a single, hybrid or multi-cloud solution.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices, and information about the publication of two recent Device Safety Information pages. The article also includes information on a recent National Patient Safety Alert...
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
How to manage a temporary storage facility, how to handle goods, what records to keep, how to increase the size of, or move goods between facilities.
Sun Pharma UK Ltd has informed the MHRA of a labelling issue with one batch of Gemcitabine 2000mg/200ml infusion.
Information on how the CMA investigated the merger, and how you can find out more.
This page includes summaries of the winning bids for the Future Open Networks Research Challenge.
How we ensure that the State Pension you get is not affected if you were unable to work because you could not demonstrate your lawful status in the UK.
Novartis Pharmaceuticals UK Limited is recalling Adakveo 10 mg/ml concentrate for solution for infusion due to the benefit-risk balance of Adakveo no longer being considered favourable by the MHRA.
An Environment Agency fisheries team has transformed a weir on the River Thames to allow eels to get past it and swim upstream.
Veriton Pharma Limited is recalling a specific batch of Epistatus (midazolam) 2.5mg Oromucosal Solution (pre-filled oral syringes) due to confirmed out of specification results related to the product appearance.
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
Guidance on using the sickle cell and thalassaemia (SCT) newborn outcomes solution web system.
This collection brings together the CHIEF error codes.
Summaries of Enforcement Undertakings from businesses accepted by OPSS and their associated Completion Certificates.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).